Joshua Kemp

Joshua Kemp

Auto-generated profile, based on publicly available information

Joshua Kemp

Department of Psychiatry and Human Behavior, Alpert Medical School, Brown University, Providence, RI, United States

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2023 in Cognitive Behaviour Therapy
Verified
Journal Article
Closed access
TWTyler B. Wray
Tyler B. Wray
JKJoshua J. Kemp
Joshua J. Kemp
MLMargo Adams Larsen
Margo Adams Larsen
Anxiety disorders are a significant cause of disability globally, yet only one in ten sufferers receives adequate quality treatment. Exposure-based therapies are effective in reducing symptoms associated with a number of anxiety disorders. However, few therapists use exposure techniques to treat these conditions, even when they are adequately trained in them, often because of concerns about provoking distress, drop out, logistical barriers, and other concerns. Virtual reality exposure therapy (VRET) can address many of these concerns, and a large body of research decisively shows that VRET is as efficacious for treating these conditions as in vivo exposures. Yet, use of VRET remains low. In this article, we discuss several factors we believe are contributing to low VRET adoption among therapists and raise potential solutions to address them. We consider steps that VR experience developers and researchers might take, such as leading studies of VRET's real-world effectiveness and treatment optimization trials and continuing to improve the fit of platforms with clinicians' workflows. We also discuss steps to address therapist reservations using aligned implementation strategies, as well as barriers for clinics, and the roles that professional organizations and payers could have in improving care by encouraging adoption of VRET.

15 February 2023 in Frontiers in Psychiatry
Verified
Journal Article
Open access
JKJoshua Kemp
Joshua Kemp
KBKristen Benito
Kristen Benito
JHJennifer Herren
Jennifer Herren
ZBZoe Brown
Zoe Brown
HFHannah E. Frank
Hannah E. Frank
JFJennifer Freeman
Jennifer Freeman
Background: Exposure therapy is a highly effective but underutilized treatment for anxiety disorders. A primary contributor to its underutilization is therapist-level negative beliefs about its safety and tolerability for patients. Given functional similarities between anxious beliefs among patients and negative beliefs among therapists, the present protocol describes how exposure principles can be leveraged during training to target and reduce therapist negative beliefs.Methods: The study will take place in two phases. First, is a case-series analysis to fine-tune training procedures that is already complete, and the second is an ongoing randomized trial that tests the novel exposure to exposure (E2E) training condition against a passive didactic approach. A precision implementation framework will be applied to evaluate the mechanism(s) by which training influences aspects of therapist delivery following training.Anticipated results: It is hypothesized that the E2E training condition will produce greater reductions in therapists’ negative beliefs about exposure during training relative to the didactic condition, and that greater reduction in negative beliefs will be associated with higher quality exposure delivery as measured by coding of videotaped delivery with actual patients.Conclusion: Implementation challenges encountered to date are discussed along with recommendations for future training interventions. Considerations for expansion of the E2E training approach are also discussed within the context of parallel treatment and training processes that may be tested in future training trials.

1 December 2020 in Journal of Anxiety Disorders
Verified
Journal Article
Closed access
CGChristopher Georgiadis
Christopher Georgiadis
MSMeghan Schreck
Meghan Schreck
MGMaddi Gervasio
Maddi Gervasio
JKJoshua Kemp
Joshua Kemp
JFJennifer Freeman
Jennifer Freeman
BCBrady Case
Brady Case

4 July 2020 in Journal of Clinical Child & Adolescent Psychology
Verified
Journal Article
Closed access
JKJoshua Kemp
Joshua Kemp
DBDavid Barker
David Barker
KBKristen Benito
Kristen Benito
JHJennifer Herren
Jennifer Herren
JFJennifer Freeman
Jennifer Freeman
This brief report examines the evidence for moderators of psychosocial treatment for youth with obsessive-compulsive disorder (OCD). Understanding treatment moderators can help clinicians select the most appropriate intervention for a particular patient and consequently increase the likelihood of initial response. A systematic search of the literature was conducted to identify randomized trials and meta-analyses reporting on moderators of psychosocial treatment for pediatric OCD. All studies included a comparison of cognitive-behavioral therapy (CBT) to active or control conditions. Few studies have evaluated moderators of psychosocial treatment for youth with OCD, and among those studies, few variables have demonstrated a differential effect on treatment response. Moderator analyses require large samples to garner the statistical power necessary to adequately evaluate differential responding in subgroups, and unfortunately, most reports of moderators in this review are post-hoc investigations of datasets from trials with relatively small sample sizes. Given the overwhelming number of CBT treatment variants and potential moderators, it would be impossible to conduct all the necessary head-to-head trials with sufficient sample sizes to develop helpful clinical guidelines. The best option for advancing the moderator literature is to utilize advanced statistical approaches for pooling existing data sets. Recommendations for leveraging emerging techniques in individual participant data meta-analysis (IPD-MA) are briefly discussed.

18 July 2025 in Current Psychiatry Reports
Verified
Journal Article
Closed access
HKHyungjin Kim
Hyungjin Kim
EHEmily C. Han
Emily C. Han
PMPhoebe B. Muntz
Phoebe B. Muntz
JKJoshua Kemp
Joshua Kemp

2 November 2018 in Cognitive Behaviour Therapy
Verified
Journal Article
Closed access
JKJoshua J. Kemp
Joshua J. Kemp
SBShannon M. Blakey
Shannon M. Blakey
KWKate B. Wolitzky-Taylor
Kate B. Wolitzky-Taylor
JSJennifer T. Sy
Jennifer T. Sy
BDBrett J. Deacon
Brett J. Deacon
This study re-analyzes data from Sy and colleagues (2011; Behaviour Research and Therapy, 49, 305–314) comparing safety behavior availability (SBA) to safety behavior utilization (SBU) during exposure therapy for claustrophobic concerns. The present investigation assessed differential rates of inhibitory learning (i.e. change in danger expectancy and coping self-efficacy) between SBA and SBU before, during, and after a single-session treatment. Thirty-nine participants with marked claustrophobic fear completed six consecutive 5-minute exposure trials in a claustrophobia chamber. Participants in the SBA condition exhibited more interference with inhibitory learning relative to the SBU condition. Danger expectancy was significantly higher in the SBA group and decreased at a markedly slower rate across exposure trials relative to SBU. Coping self-efficacy was also significantly lower among participants in the SBA condition, although groups demonstrated similar rates of change across trials. Limitations, clinical implications, and future directions are discussed.